Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.
about
Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human PathologyDevelopment of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone diseaseMineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis.Role of TGF-β in a mouse model of high turnover renal osteodystrophy.Protection of Chinese herbs against adenine-induced chronic renal failure in rats.FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.Mechanisms linking osteoporosis with cardiovascular calcification.The mechanism of phosphorus as a cardiovascular risk factor in CKDBiodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal FailureRole of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy.Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.Phosphate: an old bone molecule but new cardiovascular risk factor.Klotho preservation via histone deacetylase inhibition attenuates chronic kidney disease-associated bone injury in mice.Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D.Parathyroid gland regulation: contribution of the in vivo and in vitro models.Chinese herbal medicine Shenqi Detoxification Granule inhibits fibrosis in adenine induced chronic renal failure rats.Transient severe metastatic calcification in acute renal failure.A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failureAdvanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy.Endothelin A receptor blocker and calcimimetic in the adenine rat model of chronic renal insufficiency.NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy.Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice.Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model.Metanephros transplantation inhibits the progression of vascular calcification in rats with adenine-induced renal failure.Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.Renoprotective effects of aliskiren on adenine-induced tubulointerstitial nephropathy: possible underlying mechanisms.Vitamin D in Vascular Calcification: A Double-Edged Sword?Effect of cross-linked chitosan iron (III) on vascular calcification in uremic ratsLinkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
P2860
Q26781300-CA55CCB9-A1CA-4D7C-ADFA-202FEDDB2A4CQ30852321-CED95A65-E316-45A6-9575-0B3CA68AAFBDQ33580238-DC40C660-C687-461B-ACE1-99C3BC6AFCCFQ33822402-59E62034-B8A0-492F-AE01-91838491FB1EQ33827652-8FD4B32B-3EDA-4012-BB03-49CC13C3DC54Q33951835-618FE7C4-07D9-4E91-B22C-26A2B73AB162Q35065731-E3F4E4E5-EB39-455B-8223-8B716735E6E3Q35575965-FCD0A6D1-000A-4185-99E4-096C330AD61DQ36677622-252CCC3F-8F33-4FEA-8BDD-1F7DD6777A8EQ36925093-35302469-8B16-4707-BFD6-959991DDEFCBQ37151553-B3C7DA30-F6E2-4C46-9700-6054D584FB03Q37230788-FC048442-8D7F-45A2-B747-9C0378838C0EQ37492019-FD3A267C-9627-4762-AC00-7C78177BA981Q37741267-B5D084DF-BE60-4E1A-86CC-BAFBB0AC1AF2Q37842680-F1027FCA-7DAA-4F2B-B15A-028D6C149258Q38028534-A2B0AC3D-6E99-4488-880F-63CD44FD17AFQ38312509-7B635A3B-DC20-4954-ADF9-F8916A9FF040Q42058446-5519EF2C-6A57-4F57-9F1C-7C098D5FE50DQ42708993-9981275C-DE2A-4B15-A586-5DD6AF36B02EQ42745707-D963E7AD-18EC-458B-84E8-8A2DB34390ADQ42814528-4F2244FB-7ED9-4760-8E26-9BED72656B5CQ43237868-146F14E1-8F62-4B63-8282-B1DBB9AD3CF9Q44679349-15C097ED-FD54-4D4D-9B69-E140CDC1E070Q45737380-B6CDE2FD-630A-4875-8B8C-C271FE8ED14AQ46753404-FE52C50F-75B4-4DE6-8971-0E2905D62F70Q53183120-E7AD8F53-C90B-460A-96AC-E7044BA29109Q53667873-94BDC034-D656-45A4-998C-080EF2173CA7Q53759933-34A4CEFD-DE85-45D2-AE8F-BAF2DD505653Q54956836-2CD11F6C-0DBA-48FA-B0CF-76FCC45743C7Q57214099-FDDD7F6C-4553-4D95-9B59-765AEE697D20Q58780154-EBF5FB47-8CDE-4BAF-8434-ABDCFF9972B9
P2860
Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Severe hyperparathyroidism wit ...... with adenine-induced uraemia.
@en
Severe hyperparathyroidism wit ...... with adenine-induced uraemia.
@nl
type
label
Severe hyperparathyroidism wit ...... with adenine-induced uraemia.
@en
Severe hyperparathyroidism wit ...... with adenine-induced uraemia.
@nl
prefLabel
Severe hyperparathyroidism wit ...... with adenine-induced uraemia.
@en
Severe hyperparathyroidism wit ...... with adenine-induced uraemia.
@nl
P2093
P2860
P356
P1476
Severe hyperparathyroidism wit ...... s with adenine-induced uraemia
@en
P2093
Hiroyuki Ohkawa
Ikuo Imazeki
Kazuo Takeda
Nobuo Imai
Qunsheng Yuan
Susumu Sasaki
Yoshiyuki Moriguchi
P2860
P304
P356
10.1093/NDT/GFI273
P407
P577
2005-11-25T00:00:00Z